2005
DOI: 10.25030/ncs-015
|View full text |Cite
|
Sign up to set email alerts
|

NCS Report 15: Quality assurance of 3-D treatment planning systems for external photon and electron beams

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
9
0
3

Year Published

2008
2008
2022
2022

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(12 citation statements)
references
References 12 publications
0
9
0
3
Order By: Relevance
“…Several recommendations for quality assurance of TPS have been published by various national and international organizations. (1,6,(9)(10)(11) In 2004, European Society for Therapeutic Radiotherapy and Oncology (ESTRO) published Booklet No. 7 (6) as a more practical recommendation for commissioning of TPS.…”
Section: Discussionmentioning
confidence: 99%
“…Several recommendations for quality assurance of TPS have been published by various national and international organizations. (1,6,(9)(10)(11) In 2004, European Society for Therapeutic Radiotherapy and Oncology (ESTRO) published Booklet No. 7 (6) as a more practical recommendation for commissioning of TPS.…”
Section: Discussionmentioning
confidence: 99%
“…Monitoring the agreement between the TPS and the verification system during clinical use can aid in identifying regions where beam models or data may be improved, but such monitoring is not a substitute for the commissioning of either system. Both the TPS and the verification system should be fully tested and commissioned following accepted guidelines 5,14,15 prior to clinical use. A key result from commissioning tests is the establishment of the expected accuracy of the primary TPS and MUV system in clinically relevant situations.…”
Section: Limitations Of the Verification Calculationmentioning
confidence: 99%
“…NCS15 [27]. The tests described in that report remain valid for a stereotactic treatment planning system.…”
Section: General Remarksmentioning
confidence: 95%
“…The tests described in that report remain valid for a stereotactic treatment planning system. Tolerances of 2 mm and 2% are often quoted [27,51,130], except for field sizes below 1x1 cm² where 5-6% dose differences are tolerated. Most recommendations of NCS15 remain valuable for the stereotactic treatment planning system, but the distance to agreement for individual beams is reduced to 1 mm or better [51,126].…”
Section: General Remarksmentioning
confidence: 99%